Novo Nordisk's pricing tactics within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of value gouging, declaring the stark contrast among U.S. costs and those in Europe and copyright.On the other hand, it's important to stay informed that these personal savings mightn't apply universally, P